- Trials with a EudraCT protocol (15)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
15 result(s) found for: favipiravir.
Displaying page 1 of 1.
EudraCT Number: 2020-001904-41 | Sponsor Protocol Number: GETAFIX-2020 | Start Date*: 2020-05-20 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: Glasgow Early Treatment Arm FavIpiravir : A randomized controlled study of favipiravir as an early treatment arm in COVID-19 patients | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001387-10 | Sponsor Protocol Number: 220301 | Start Date*: 2022-12-29 | |||||||||||
Sponsor Name:TECNIMEDE, Sociedade Técnico-Medicinal, S.A. | |||||||||||||
Full Title: A Phase 3, Multicenter, Prospective, Placebo-Controlled, Randomized, Double-Blind Study to Assess the Efficacy and Safety of Favipiravir in Non-critical Hospitalized Patients with COVID-19 Pneumoni... | |||||||||||||
Medical condition: Coronavirus disease 2019 (COVID-19 pneumonia) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002753-22 | Sponsor Protocol Number: FAVID-01-20-SP | Start Date*: 2020-09-02 | |||||||||||
Sponsor Name:Ferrer Internacional, S.A. | |||||||||||||
Full Title: Safety and Efficacy of Favipiravir in COVID-19 Patients with Pneumonia −A randomized, double blind, placebo- controlled study − | |||||||||||||
Medical condition: Patients diagnosed with COVID-19 by positive PCR for SARS-COV2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-006042-39 | Sponsor Protocol Number: HUN-FAVI-02 | Start Date*: 2021-02-19 | |||||||||||
Sponsor Name:Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of Favipiravir-HU compared to placebo as add-on therapy to standard of care in asymptomatic to mild severity C... | |||||||||||||
Medical condition: Patients with PCR confirmed SARS-CoV-2 infection who are asymptomatic or have mild symptoms will be enrolled | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005128-12 | Sponsor Protocol Number: T705-COVID-GCRI-Protocol-A | Start Date*: 2021-02-01 |
Sponsor Name:Vilnius University Hospital Santaros klinikos | ||
Full Title: An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild Pneumonia − An open-label randomized controlled study | ||
Medical condition: COVID-19 Patients with Mild Pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Prohibited by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002106-68 | Sponsor Protocol Number: CTU/2020/354 | Start Date*: 2020-07-16 | |||||||||||
Sponsor Name:University College London Comprehensive Clinical Trial Unit | |||||||||||||
Full Title: Favipiravir, lopinavir/ritonavir or combination therapy: a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19 | |||||||||||||
Medical condition: SARS-CoV-2 (Corona virus) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001608-40 | Sponsor Protocol Number: HS216C17(MRCT) | Start Date*: 2020-07-15 |
Sponsor Name:Zhejiang Hisun Pharmaceutical Co. Ltd. | ||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Adult Patients with COVID-19-Moderate Type | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002149-13 | Sponsor Protocol Number: T705aUS316 | Start Date*: 2013-08-29 | |||||||||||
Sponsor Name:MDVI, LLC | |||||||||||||
Full Title: A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza | |||||||||||||
Medical condition: Uncomplicated influenza. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) BG (Completed) NL (Completed) ES (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001449-38 | Sponsor Protocol Number: CW002 | Start Date*: 2020-04-29 | |||||||||||
Sponsor Name:Chelsea and Westminster Hospital NHS Foundation Trust | |||||||||||||
Full Title: A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe | |||||||||||||
Medical condition: COVID-19 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002728-35 | Sponsor Protocol Number: HUN-AVI-01 | Start Date*: 2020-09-17 | |||||||||||
Sponsor Name:Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium | |||||||||||||
Full Title: An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild Pneumonia − An open-label randomized controlled study − | |||||||||||||
Medical condition: Patients with new type of coronavirus (SARS-CoV-2) infection proven by RT-PCR test with mild pneumonia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005214-18 | Sponsor Protocol Number: T705-COVID-GCRI-Protocol-B | Start Date*: 2021-02-01 |
Sponsor Name:Vilnius University Hospital Santaros klinikos | ||
Full Title: An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia − An open-label randomized controlled study | ||
Medical condition: COVID-19 Patients without Pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Prohibited by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001435-27 | Sponsor Protocol Number: CHUBX2020/12 | Start Date*: 2020-04-10 |
Sponsor Name:CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX, ETABLISSEMENT PUBLIC | ||
Full Title: Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety of several experimental treat... | ||
Medical condition: severe acute respiratory syndrome coronavirus 2(SARS-CoV 2) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001457-43 | Sponsor Protocol Number: APHP200388 | Start Date*: 2020-04-10 |
Sponsor Name:APHP | ||
Full Title: Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia | ||
Medical condition: acute hypoxemic respiratory failure (AHRF) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001528-32 | Sponsor Protocol Number: ARCO-Homestudy | Start Date*: 2020-05-14 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE "LAZZARO SPALLANZANI" | |||||||||||||
Full Title: Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals | |||||||||||||
Medical condition: Coronavirus Covid 19 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005951-19 | Sponsor Protocol Number: APL-D-003-20 | Start Date*: 2021-06-08 | |||||||||||
Sponsor Name:Pharma Mar, S.A. | |||||||||||||
Full Title: A Phase 3, Multicentre, Randomised, Controlled Trial to Determine the Efficacy and Safety of Two Dose Levels of Plitidepsin Versus Control in Adult Patients Requiring Hospitalisation for Management... | |||||||||||||
Medical condition: moderate COVID-19 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) BG (Prematurely Ended) GR (Prematurely Ended) PT (Prematurely Ended) ES (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
